Use of protein G microcolumns in chromatographic immunoassays: A comparison of competitive binding formats

被引:7
|
作者
Pfaunmiller, Erika L. [1 ]
Anguizola, Jeanethe A. [1 ]
Milanuk, Mitchell L. [1 ]
Carter, NaTasha [1 ]
Hage, David S. [1 ]
机构
[1] Univ Nebraska, Dept Chem, 704 Hamilton Hall, Lincoln, NE 68588 USA
基金
美国国家卫生研究院; 美国国家科学基金会;
关键词
Chromatographic immunoassay; Affinity microcolumn; Protein G; Competitive binding immunoassay; Human serum albumin; FLOW-INJECTION IMMUNOASSAY; SPLIT-PEAK CHROMATOGRAPHY; FREE DRUG FRACTIONS; CAPILLARY; MODEL; IMMOBILIZATION; ASSAYS;
D O I
10.1016/j.jchromb.2015.12.055
中图分类号
Q5 [生物化学];
学科分类号
071010 ; 081704 ;
摘要
Affinity microcolumns containing protein G were used as general platforms for creating chromatographic based competitive binding immunoassays. Human serum albumin (HSA) was used as a model target for this work and HSA tagged with a near infrared fluorescent dye was utilized as the label. The protein G microcolumns were evaluated for use in several assay formats, including both solution-based and column-based competitive binding immunoassays and simultaneous or sequential injection formats. All of these methods were characterized by using the same amounts of labeled HSA and anti-HSA antibodies per sample, as chosen for the analysis of a protein target in the low-to-mid ng/mL range. The results were used to compare these formats in terms of their response, precision, limit of detection, and analysis time. All these methods gave detection limits in the range of 8-19 ng/mL and precisions ranging from +/- 5% to +/- 10% when using an injection flow rate of 0.10 mL/min. The column-based sequential injection immunoassay provided the best limit of detection and the greatest change in response at low target concentrations, while the solution-based simultaneous injection method had the broadest linear and dynamic ranges. These results provided valuable guidelines that can be employed to develop and extend the use of protein G microcolumns and these competitive binding formats to other protein biomarkers or biological agents of clinical or pharmaceutical interest. (C) 2015 Elsevier B.V. All rights reserved.
引用
收藏
页码:91 / 100
页数:10
相关论文
共 50 条